450 related articles for article (PubMed ID: 19481696)
1. Preparation of hydrocortisone nanosuspension through a bottom-up nanoprecipitation technique using microfluidic reactors.
Ali HS; York P; Blagden N
Int J Pharm; 2009 Jun; 375(1-2):107-13. PubMed ID: 19481696
[TBL] [Abstract][Full Text] [Related]
2. Preparation and characterization of freeze-dried 2-methoxyestradiol nanoparticle powders.
Du B; Li XT; Zhao Y; A YM; Zhang ZZ
Pharmazie; 2010 Jul; 65(7):471-6. PubMed ID: 20662313
[TBL] [Abstract][Full Text] [Related]
3. Hydrocortisone nanosuspensions for ophthalmic delivery: A comparative study between microfluidic nanoprecipitation and wet milling.
Ali HS; York P; Ali AM; Blagden N
J Control Release; 2011 Jan; 149(2):175-81. PubMed ID: 20946923
[TBL] [Abstract][Full Text] [Related]
4. [Development of Silymarin nanocrystals lyophilized power applying nanosuspension technology].
Zhao X; Wang G; Zhang B; Li H; Nie Q; Zang C; Zhao X
Zhongguo Zhong Yao Za Zhi; 2009 Jun; 34(12):1503-8. PubMed ID: 19777833
[TBL] [Abstract][Full Text] [Related]
5. Development of novel polymer-stabilized diosmin nanosuspensions: in vitro appraisal and ex vivo permeation.
Freag MS; Elnaggar YS; Abdallah OY
Int J Pharm; 2013 Sep; 454(1):462-71. PubMed ID: 23830765
[TBL] [Abstract][Full Text] [Related]
6. Preparation of a chemically stable quercetin formulation using nanosuspension technology.
Gao L; Liu G; Wang X; Liu F; Xu Y; Ma J
Int J Pharm; 2011 Feb; 404(1-2):231-7. PubMed ID: 21093559
[TBL] [Abstract][Full Text] [Related]
7. A comparative study of top-down and bottom-up approaches for the preparation of micro/nanosuspensions.
Verma S; Gokhale R; Burgess DJ
Int J Pharm; 2009 Oct; 380(1-2):216-22. PubMed ID: 19596059
[TBL] [Abstract][Full Text] [Related]
8. Preparation of stable nitrendipine nanosuspensions using the precipitation-ultrasonication method for enhancement of dissolution and oral bioavailability.
Xia D; Quan P; Piao H; Piao H; Sun S; Yin Y; Cui F
Eur J Pharm Sci; 2010 Jul; 40(4):325-34. PubMed ID: 20417274
[TBL] [Abstract][Full Text] [Related]
9. Distribution of an intravenous injectable nimodipine nanosuspension in mice.
Xiong R; Lu W; Yue P; Xu R; Li J; Chen T; Wang P
J Pharm Pharmacol; 2008 Sep; 60(9):1155-9. PubMed ID: 18718118
[TBL] [Abstract][Full Text] [Related]
10. Micronization of atorvastatin calcium by antisolvent precipitation process.
Zhang HX; Wang JX; Zhang ZB; Le Y; Shen ZG; Chen JF
Int J Pharm; 2009 Jun; 374(1-2):106-13. PubMed ID: 19446766
[TBL] [Abstract][Full Text] [Related]
11. Particle size tailoring of ursolic acid nanosuspensions for improved anticancer activity by controlled antisolvent precipitation.
Wang Y; Song J; Chow SF; Chow AH; Zheng Y
Int J Pharm; 2015 Oct; 494(1):479-89. PubMed ID: 26302857
[TBL] [Abstract][Full Text] [Related]
12. A continuous and highly effective static mixing process for antisolvent precipitation of nanoparticles of poorly water-soluble drugs.
Dong Y; Ng WK; Hu J; Shen S; Tan RB
Int J Pharm; 2010 Feb; 386(1-2):256-61. PubMed ID: 19922777
[TBL] [Abstract][Full Text] [Related]
13. Solid lipid nanodispersions containing mixed lipid core and a polar heterolipid: characterization.
Attama AA; Schicke BC; Paepenmüller T; Müller-Goymann CC
Eur J Pharm Biopharm; 2007 Aug; 67(1):48-57. PubMed ID: 17276663
[TBL] [Abstract][Full Text] [Related]
14. Artificial neural networks modelling the prednisolone nanoprecipitation in microfluidic reactors.
Ali HS; Blagden N; York P; Amani A; Brook T
Eur J Pharm Sci; 2009 Jun; 37(3-4):514-22. PubMed ID: 19406230
[TBL] [Abstract][Full Text] [Related]
15. A stable hydrocortisone nanosuspension for improved dissolution: Preparation, characterization and in vitro evaluation.
Ali HS; Khan S; York P; Shah SM; Khan J; Hussain Z; Khan BA
Pak J Pharm Sci; 2017 Sep; 30(5):1635-1643. PubMed ID: 29084684
[TBL] [Abstract][Full Text] [Related]
16. A quality-by-design study to develop Nifedipine nanosuspension: examining the relative impact of formulation variables, wet media milling process parameters and excipient variability on drug product quality attributes.
Patel PJ; Gajera BY; Dave RH
Drug Dev Ind Pharm; 2018 Dec; 44(12):1942-1952. PubMed ID: 30027778
[TBL] [Abstract][Full Text] [Related]
17. Diclofenac-loaded Eudragit S100 nanosuspension for ophthalmic delivery.
Ahuja M; Dhake AS; Sharma SK; Majumdar DK
J Microencapsul; 2011; 28(1):37-45. PubMed ID: 21171815
[TBL] [Abstract][Full Text] [Related]
18. Stability of lipid excipients in solid lipid nanoparticles.
Radomska-Soukharev A
Adv Drug Deliv Rev; 2007 Jul; 59(6):411-8. PubMed ID: 17553589
[TBL] [Abstract][Full Text] [Related]
19. Investigation of preparation parameters of nanosuspension by top-down media milling to improve the dissolution of poorly water-soluble glyburide.
Singh SK; Srinivasan KK; Gowthamarajan K; Singare DS; Prakash D; Gaikwad NB
Eur J Pharm Biopharm; 2011 Aug; 78(3):441-6. PubMed ID: 21439378
[TBL] [Abstract][Full Text] [Related]
20. Nanosuspension as an ophthalmic delivery system for certain glucocorticoid drugs.
Kassem MA; Abdel Rahman AA; Ghorab MM; Ahmed MB; Khalil RM
Int J Pharm; 2007 Aug; 340(1-2):126-33. PubMed ID: 17600645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
